CLINICAL_TRIALS
trial_result
· 2024-10-29
Clinical Trial Update: A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma [Phase 1]
Summary
Phase 1b study evaluating ONL1204 ophthalmic solution for progression of open-angle glaucoma has completed enrollment/status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ONL Therapeutics | Conditions: Open Angle Glaucoma | Phase 1 | Status: COMPLETED